Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline

San Mateo, Calif, Nov 14, 2018– Attenua, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, today announced that the first patient has been treated in a Phase 2 clinical trial in chronic...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials